Multicenter Study of Molecular Epidemiology and Antibiotic Resistance of Group A Streptococci in 2008-2009 in Korea
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: Group A Streptococcus (GAS) is responsible for a wide spectrum of human diseases. We investigated the distribution of emm types and antibiotic resistance rates of GAS from clinical specimens in several Korean medical centers. Methods: A total of 192 strains of GAS from throat, blood, and other specimens collected in Seoul, Busan, Ulsan, Iksan, and Jeju were studied in 2008-2009. The emm genotypes were identified using PCR and sequencing. Antimicrobial susceptibility testing was performed by disk diffusion. Phenotypes of macrolide resistance were evaluated, and macrolide resistance genes were determined by PCR. Results: The emm89 (33.9%) was most frequently detected, followed by emm1 (12.5%), emm12 (8.3%), emm4 (7.8%), and emm75 (7.3%). The distribution of emm types did not show a close relation to the type of specimen and was rather different for each area. The resistance rates to erythromycin (ERY) and clindamycin (CLI) were 4.6% and 3.7%, respectively. Among the 9 ERY-resistant strains, the rate of constitutive resistance was 88.9%, compared with 11.1% for the M phenotype. Five of the ERY-resistant strains were emm28. Conclusion: This multicenter study reveals heterogenous emm genotypes by geographic area. Rates of resistance to ERY and CLI were low, and most of the ERY-resistant strains showed a constitutive macrolide- lincosamide-streptogramin B (cMLSB) phenotype.
Abstract
Background: Group A Streptococcus (GAS) is responsible for a wide spectrum of human diseases. We investigated the distribution of emm types and antibiotic resistance rates of GAS from clinical specimens in several Korean medical centers. Methods: A total of 192 strains of GAS from throat, blood, and other specimens collected in Seoul, Busan, Ulsan, Iksan, and Jeju were studied in 2008-2009. The emm genotypes were identified using PCR and sequencing. Antimicrobial susceptibility testing was performed by disk diffusion. Phenotypes of macrolide resistance were evaluated, and macrolide resistance genes were determined by PCR. Results: The emm89 (33.9%) was most frequently detected, followed by emm1 (12.5%), emm12 (8.3%), emm4 (7.8%), and emm75 (7.3%). The distribution of emm types did not show a close relation to the type of specimen and was rather different for each area. The resistance rates to erythromycin (ERY) and clindamycin (CLI) were 4.6% and 3.7%, respectively. Among the 9 ERY-resistant strains, the rate of constitutive resistance was 88.9%, compared with 11.1% for the M phenotype. Five of the ERY-resistant strains were emm28. Conclusion: This multicenter study reveals heterogenous emm genotypes by geographic area. Rates of resistance to ERY and CLI were low, and most of the ERY-resistant strains showed a constitutive macrolide- lincosamide-streptogramin B (cMLSB) phenotype.
참고문헌 (19)
- Eriksson BK, "Group A streptococcal infections in Sweden: a comparative study of invasive and noninvasive infections and analysis of dominant T28 emm28 isolates", Clin Infect Dis, 37, pp.1189~1193 (2003)
- Shulman ST, "North American Streptococcal Pharyngitis Surveillance Group. Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates", Clin Infect Dis, 49, pp.78~84 (2009)
- Beall B, "Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci", J Clin Microbiol, 34, pp.953~958 (1996)
- 최은화, "Macrolide계 항균제 내성 출현과 소아에서의 임상적 적용", Korean Journal of Pediatrics, 51(10), pp.1031~1037 (2008), 대한소아과학회
- Kim S, "Antibiotic resistance and genotypic characteristics of group a streptococci associated with acute pharyngitis in Korea", Microb Drug Resist, 10, pp.300~305 (2004)
- Yi YH, "Characterization of erythromycin resistance of Streptococcus pyogenes isolated from pharyngitis patients in Korea", Jpn J Infect Dis, 59, pp.192~194 (2006)
- Chang H, "Antibiotic resistance and molecular analysis of Streptococcus pyogenes isolated from healthy schoolchildren in China", Scand J Infect Dis, 42, pp.84~89 (2010)
- Katz KC, "Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001", Antimicrob Agents Chemother, 47, pp.2370~2372 (2003)
- Pérez-Trallero E, "Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005", Antimicrob Agents Chemother, 51, pp.1228~1233 (2007)
- Murakami J, "Distribution of emm genotypes and superantigen genes of Streptococcus pyogenes isolated in Japan, 1994-9", Epidemiol Infect, 128, pp.397~404 (2002)
- Lee SY, "Streptococcal toxic shock syndrome associated with intrauterine fetal death: a case report", Korean J Clin Microbiol, 1, pp.109~112 (1998)
- Chan JC, "Epidemiological analysis of Streptococcus pyogenes infections in Hong Kong", Pathology, 41, pp.681~686 (2009)
- McNeil SA, "Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers", Clin Infect Dis, 41, pp.1114~1122 (2005)
- 고은하, "Decline in Erythromycin Resistance in Group A Streptococci from Acute Pharyngitis due to Changes in the emm Genotypes Rather Than Restriction of Antibiotic Use", Annals of Laboratory Medicine, 30(5), pp.485~490 (2010), 대한진단검사의학회
- Oliver MA, "Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain)", J Antimicrob Chemother, 60, pp.450~452 (2007)
- Ardanuy C, "Molecular characterization of macrolide- and multidrugresistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008)", J Antimicrob Chemother, 65, pp.634~643 (2010)
- Seppälä H, "The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland", N Engl J Med, 337, pp.441~446 (1997), Finnish Study Group for Antimicrobial Resistance
- Bass JW, "Decline of erythromycin resistance of group A beta-hemolytic streptococci in Japan. Comparison with worldwide reports", Arch Pediatr Adole sc Med, 148, pp.67~71 (1994)
- Green MD, "Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA", J Antimicrob Chemother, 57, pp.1240~1243 (2006)